A two-year extension to a one-year, multicenter, open-label, randomised study to evaluate the safety and efficacy of FTY720 combined with tacrolimus and steroids versus mycophenolate mofetyl combined with tacrolimus and steroids, in de novo adult renal transplant recipients.

Trial Profile

A two-year extension to a one-year, multicenter, open-label, randomised study to evaluate the safety and efficacy of FTY720 combined with tacrolimus and steroids versus mycophenolate mofetyl combined with tacrolimus and steroids, in de novo adult renal transplant recipients.

Completed
Phase of Trial: Phase III

Latest Information Update: 15 Jul 2016

At a glance

  • Drugs Fingolimod (Primary) ; Mycophenolate mofetil (Primary) ; Corticosteroids; Tacrolimus
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 01 Nov 2011 Actual end date (Dec 2005) added as reported by ClinicalTrials.gov.
    • 17 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top